AVXL logo

Anavex Life Sciences Corp. (AVXL)

Profile

Full Name

Anavex Life Sciences Corp.

Ticker

NASDAQ: AVXL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 2, 2006

Indexes

Not included

Website

https://www.anavex.com

Employees

42

Key Details

Price

$8.71(-0.29%)

Market Cap

$748.56M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.52(13.47% YoY)

PE Ratio

-

Next earnings date

Nov 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.71
    AVXL price is $8.71

    30-Day Relative Volume

    1.13
    AVXL 30-day relative volume is 1.13

    Price Performance

    Price 1-Day Change

    -0.29%
    AVXL price is down -0.29% today

    Price YTD Change

    -18.85%
    AVXL price is down -18.85% since January 1st

    Price 1-Year Change

    +63.51%
    AVXL price is up +63.51% year-on-year

    Price 3-Year Change

    -25.96%
    AVXL price is down -25.96% over the past 3 years

    Price Range

    Price All-Time High

    $31.50
    AVXL price is currently -72.33% below its historical high of $31.50

    Price 3-Year Low

    $3.25
    AVXL price is currently +168.15% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $748.56M
    AVXL market cap is $748.56 million

    Market Cap 3-Year Change

    -18.4%
    AVXL market cap is down -18.4% over the past 3 years

    Market Cap All-Time High

    $2.09B
    AVXL market cap is currently -64.18% below its historical high of $2.09 billion

    Market Cap Sector Percentile

    66.98%
    AVXL market cap is higher than 66.98% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.3%
    AVXL shares outstanding is up +1.3% year-on-year

    Shares Outstanding 3-Year Change

    +10.2%
    AVXL shares outstanding is up +10.2% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.12
    AVXL beta is 1.12

    200-day SMA

    $9.32
    AVXL price is currently -6.52% below its 200-day simple moving average

    50-day SMA

    $9.24
    AVXL price is currently -5.68% below its 50-day simple moving average

    14-Day RSI

    43.00
    AVXL 14-day relative strength index is 43.00

    Volume

    1.13
    AVXL 30-day relative volume is 1.13

    ATR

    $0.54
    AVXL average true range is $0.54

    10-day Historical Volatility

    58.36%
    AVXL 10-day historical volatility is 58.36%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    AVXL annual revenue is $0.00

    Revenue Analysts Estimate

    -
    AVXL annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    AVXL annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.75%
    AVXL annual revenue is higher than 28.75% of companies in Healthcare sector

    EPS

    EPS

    -$0.52
    AVXL annual earnings per share is -$0.52

    EPS Analysts Estimate

    -$0.57
    AVXL annual earnings per share is currently +9.61% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +13.47%
    AVXL annual earnings per share is up +13.47% year-on-year

    EPS Sector Percentile

    66.86%
    AVXL annual earnings per share is higher than 66.86% of companies in Healthcare sector

    Profit

    Gross Profit

    $0.00
    AVXL annual gross profit is $0.00

    Gross Margin

    -
    AVXL annual gross profit margin value is unknown

    Operating Profit

    -$52.80M
    AVXL annual operating income is -$52.80 million

    Operating Margin

    -
    AVXL annual operating profit margin value is unknown

    Net Income

    -$43.00M
    AVXL annual net profit is -$43.00 million

    Net Margin

    -
    AVXL annual net profit margin value is unknown

    Expenses

    Total Expenses

    $52.80M
    AVXL annual total expenses is $52.80 million

    Operating Expenses

    $52.80M
    AVXL annual total operating expenses is $52.80 million

    Cost Of Goods Sold

    $0.00
    AVXL annual cost of goods sold is $0.00

    Selling, General & Administrative Expenses

    $11.04M
    AVXL annual SG&A is $11.04 million

    Depreciation & Amortization

    -
    AVXL annual D&A value is unknown

    Interest Expense

    $0.00
    AVXL annual interest expense is $0.00

    Income Tax

    -$2.29M
    AVXL annual income tax is -$2.29 million

    EBIT & EBITDA

    EBIT

    -$43.00M
    AVXL annual earnings before interest & taxes is -$43.00 million

    EBITDA

    -$43.00M
    AVXL annual EBITDA is -$43.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $135.57M
    AVXL annual total assets is $135.57 million

    Non Current Assets

    $0.00
    AVXL annual long term assets is $0.00

    Current Assets

    $135.57M
    AVXL annual total current assets is $135.57 million

    Cash and Cash Equivalents

    $132.19M
    AVXL annual cash & cash equivalents is $132.19 million

    Accounts Receivable

    -
    AVXL annual accounts receivable value is unknown

    Inventory

    $0.00
    AVXL annual inventory is $0.00

    Liabilities

    Total Liabilities

    $15.30M
    AVXL annual total liabilities is $15.30 million

    Long Term Liabilities

    $0.00
    AVXL annual total long term liabilities is $0.00

    Current Liabilities

    $15.30M
    AVXL annual current liabilities is $15.30 million

    Accounts Payable

    $9.63M
    AVXL annual accounts payable is $9.63 million

    Debt

    Total Debt

    $0.00
    AVXL annual total debt is $0.00

    Total Debt 1-Year Change

    0%
    AVXL annual total debt has remained unchanged year-on-year

    Long Term Debt

    $0.00
    AVXL annual long term debt is $0.00

    Short Term Debt

    $0.00
    AVXL annual short term debt is $0.00

    Equity & Capital

    Shareholders Equity

    $120.26M
    AVXL annual stockholders equity is $120.26 million

    Book Value

    $120.26M
    AVXL annual book value is $120.26 million

    Retained Earnings

    -$336.07M
    AVXL annual retained earnings is -$336.07 million

    Working Capital

    $120.26M
    AVXL annual working capital is $120.26 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$30.81M
    AVXL annual cash from operations is -$30.81 million

    Cash From Operations 1-Year Change

    -10.89%
    AVXL annual cash from operations is down -10.89% year-on-year

    Cash From Investing

    $0.00
    AVXL annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    0%
    AVXL annual cash from investing has remained unchanged year-on-year

    Cash From Financing

    $11.97M
    AVXL annual cash from financing is $11.97 million

    Cash From Financing 1-Year Change

    -59.61%
    AVXL annual cash from financing is down -59.61% year-on-year

    CAPEX

    CAPEX

    $0.00
    AVXL annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    AVXL annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    -$30.81M
    AVXL annual free cash flow is -$30.81 million

    Free Cash Flow 1-Year Change

    -10.89%
    AVXL annual free cash flow is down -10.89% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    AVXL annual gross profit margin value is unknown

    Operating Margin

    -
    AVXL annual operating profit margin value is unknown

    Net Margin

    -
    AVXL annual net profit margin value is unknown

    ROA & ROE

    ROA

    -29.66%
    AVXL annual return on assets is -29.66%

    ROE

    -32.81%
    AVXL annual return on equity is -32.81%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    AVXL price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    AVXL price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    8.23
    AVXL price to book ratio is 8.23

    PB Ratio Sector Percentile

    85.51%
    AVXL price to book ratio is higher than 85.51% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    AVXL price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    AVXL price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $647.40M
    AVXL enterprise value is $647.40 million

    Enterprise Value Sector Percentile

    66.75%
    AVXL enterprise value is higher than 66.75% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -11.79
    AVXL EV/EBITDA is -11.79

    EV/EBITDA Sector Percentile

    13.24%
    AVXL EV/EBITDA is higher than 13.24% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    8.86
    AVXL annual current ratio is 8.86

    Quick Ratio

    8.86
    AVXL annual quick ratio is 8.86

    Leverage

    Debt To Equity

    0.00
    AVXL annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    AVXL annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    AVXL piotroski f-score value is unknown

    Altman Z-Score

    25.89
    AVXL altman z-score is 25.89

    Analyst ratings

    Recent major analysts updates

    Oct 7, 25 HC Wainwright & Co.
    Buy
    Oct 2, 25 D. Boral Capital
    Buy
    Oct 1, 25 D. Boral Capital
    Buy
    Sep 10, 25 HC Wainwright & Co.
    Buy
    Sep 10, 25 D. Boral Capital
    Buy
    Aug 27, 25 D. Boral Capital
    Buy
    Aug 22, 25 HC Wainwright & Co.
    Buy
    Aug 13, 25 D. Boral Capital
    Buy
    Aug 4, 25 D. Boral Capital
    Buy
    Apr 7, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with AVXL included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Anavex Life Sciences Corp.?
    • Does Anavex Life Sciences Corp. pay dividends?
    • What sector is Anavex Life Sciences Corp. in?
    • What industry is Anavex Life Sciences Corp. in?
    • What country is Anavex Life Sciences Corp. based in?
    • When did Anavex Life Sciences Corp. go public?
    • Is Anavex Life Sciences Corp. in the S&P 500?
    • Is Anavex Life Sciences Corp. in the NASDAQ 100?
    • Is Anavex Life Sciences Corp. in the Dow Jones?
    • When was Anavex Life Sciences Corp.'s last earnings report?
    • When does Anavex Life Sciences Corp. report earnings?

    What is the ticker symbol for Anavex Life Sciences Corp.?

    The ticker symbol for Anavex Life Sciences Corp. is NASDAQ:AVXL

    Does Anavex Life Sciences Corp. pay dividends?

    No, Anavex Life Sciences Corp. does not pay dividends

    What sector is Anavex Life Sciences Corp. in?

    Anavex Life Sciences Corp. is in the Healthcare sector

    What industry is Anavex Life Sciences Corp. in?

    Anavex Life Sciences Corp. is in the Biotechnology industry

    What country is Anavex Life Sciences Corp. based in?

    Anavex Life Sciences Corp. is headquartered in United States

    When did Anavex Life Sciences Corp. go public?

    Anavex Life Sciences Corp.'s initial public offering (IPO) was on August 2, 2006

    Is Anavex Life Sciences Corp. in the S&P 500?

    No, Anavex Life Sciences Corp. is not included in the S&P 500 index

    Is Anavex Life Sciences Corp. in the NASDAQ 100?

    No, Anavex Life Sciences Corp. is not included in the NASDAQ 100 index

    Is Anavex Life Sciences Corp. in the Dow Jones?

    No, Anavex Life Sciences Corp. is not included in the Dow Jones index

    When was Anavex Life Sciences Corp.'s last earnings report?

    Anavex Life Sciences Corp.'s most recent earnings report was on August 12, 2025

    When does Anavex Life Sciences Corp. report earnings?

    The next expected earnings date for Anavex Life Sciences Corp. is November 28, 2025
    On this page